Noble Ray, Rodeck Charles H
UCL Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK.
Best Pract Res Clin Obstet Gynaecol. 2008 Feb;22(1):219-31. doi: 10.1016/j.bpobgyn.2007.07.008. Epub 2007 Sep 24.
Fetal therapy raises ethical concerns in relation to the balance of potential benefit and harm, autonomy and informed consent, and the duties of the clinician to the pregnant women and fetus. Invasive therapy should be recommended only when it has a realistic chance of saving the life of the fetus and offspring or preventing serious and irreversible disease or disability. Clinicians should respect maternal choice and assessment of risk, particularly if the therapy might be only partially successful, leaving the offspring with a profound morbidity. Fetal therapy should not be undertaken without maternal consent; nor should it be presented coercively as an option to avoid a termination of pregnancy. Therapeutic procedures of unproven efficacy should be undertaken only with the voluntary informed consent of the pregnant woman and according to a clearly defined research protocol that has been approved by an appropriate research ethics committee and where appropriate support and counselling can be provided.
胎儿治疗引发了诸多伦理问题,涉及潜在益处与危害的平衡、自主权与知情同意,以及临床医生对孕妇和胎儿的责任。只有当侵入性治疗有切实可能挽救胎儿和后代生命或预防严重且不可逆转的疾病或残疾时,才应推荐使用。临床医生应尊重母亲对风险的选择和评估,尤其是当治疗可能仅部分成功,导致后代出现严重疾病时。未经母亲同意,不应进行胎儿治疗;也不应将其作为避免终止妊娠的一种选择进行强制推荐。对于未经证实疗效的治疗程序,只有在孕妇自愿知情同意的情况下,并根据经适当研究伦理委员会批准的明确研究方案进行,且在适当时可提供支持和咨询时,才可开展。